Curative Biotechnology Inc
OTC:CUBT
Fundamental Analysis

Revenue & Expenses Breakdown
Curative Biotechnology Inc
Balance Sheet Decomposition
Curative Biotechnology Inc
Current Assets | 24.4k |
Cash & Short-Term Investments | 600 |
Other Current Assets | 23.8k |
Non-Current Assets | 2m |
PP&E | 6.4k |
Intangibles | 1.6m |
Other Non-Current Assets | 347.9k |
Free Cash Flow Analysis
Curative Biotechnology Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Curative Biotechnology Inc
Revenue
|
0
USD
|
Operating Expenses
|
-3.3m
USD
|
Operating Income
|
-3.3m
USD
|
Other Expenses
|
-791.9k
USD
|
Net Income
|
-4.1m
USD
|
CUBT Profitability Score
Profitability Due Diligence
Curative Biotechnology Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
Score
Curative Biotechnology Inc's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
CUBT Solvency Score
Solvency Due Diligence
Curative Biotechnology Inc's solvency score is 19/100. The higher the solvency score, the more solvent the company is.
Score
Curative Biotechnology Inc's solvency score is 19/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CUBT Price Targets Summary
Curative Biotechnology Inc
Dividends
Current shareholder yield for CUBT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?